Análisis de perdurabilidad de las Instituciones Prestadoras de Salud (IPS), especializadas en tratamiento de enfermedades de alto costo en el departamento de Antioquia, frente a las políticas de regulación de precios por medio de la Ley 1438 en Colombia

Abstract

From the health system reform, through Law 1438 of 2011, it was implemented in Colombia the policy of medicine price regulation and theirs biosimilars entering the country. This research analyzes the sustainability in the Institutions Health Institutions ( IPS ) specialized in treating diseases of high cost , such as: Medicarte , Clinic Astorga, Clinic Life, Helpharma , Audifarma , and Medex , to finally identify the value chain the department of Antioquia, looking propose alternatives for strategic decision-making type.